Publications by authors named "Kimberly Cockerham"

Claim this Profile
T
The role of IL-6 in thyroid eye disease: an update on emerging treatments.
Jennifer Murdock, John Nguyen, Brady J Hurtgen, Cathy Andorfer, John Walsh, Kimberly Cockerham

Front Ophthalmol (Lausanne)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy and Safety of Teprotumumab in Geriatrics Patients: A Multicenter Study.
Shreya Ashish Shah, Patcharaporn Chandraparnik, Suyoung Choi, Linus Amarikwa, Ridhima Guniganti, Kimberly Cockerham

Ophthalmic Plast Reconstr Surg· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatments.
Jennifer Murdock, John Nguyen, Brady J Hurtgen, Cathy Andorfer, John Walsh, Kimberly Cockerham

Front Ophthalmol (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series.
Shoaib Ugradar, Emanuil Parunakian, Emil Malkhasyan, Pershanjit Raika, Joseph Tolentino, Kimberly Cockerham

Graefes Arch Clin Exp Ophthalmol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply Re: "Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease".
Clara J Men, Linus Amarikwa, Brandon Pham, Connie Sears, Kevin Clauss, Kimberly Cockerham

Ophthalmic Plast Reconstr Surg· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Traumatic optic neuropathy management: a systematic review.
Richard J Blanch, Iric John Joseph, Kimberly Cockerham

Eye (Lond)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Shreya A Shah, Linus Amarikwa, Connie M Sears, Kevin D Clauss, Raneem D Rajjoub, Kimberly P Cockerham

Ophthalmology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease.
Clara J Men, Linus Amarikwa, Brandon Pham, Connie Sears, Kevin Clauss, Kimberly Cockerham

Ophthalmic Plast Reconstr Surg· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility Values.
Terry J Smith, Kimberly Cockerham, Naina Barretto, Alex Hirst, Louisa Oliver

Endocr Pract· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study.
Shreya A Shah, Linus Amarikwa, Connie M Sears, Kevin D Clauss, Raneem D Rajjoub, Kimberly P Cockerham

Ophthalmology· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Ophthalmology in Tele-Stroke Consults for Triaging Acute Vision Loss.
Anna Artymowicz, Christina Douglas, Kimberly Cockerham

Open Access Emerg Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in lacrimal gland volume and aqueous tear production following treatment with teprotumumab.
Shoaib Ugradar, Erin Zimmerman, Emanuil Parunakian, Julia Kang, Kimberly Cockerham

Clin Exp Ophthalmol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility Assessment of Moderate to Severe Thyroid Eye Disease Health States.
Terry J Smith, Kimberly Cockerham, Gary Lelli, Chitra Choudhary, Stephanie Taylor

JAMA Ophthalmol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teprotumumab for the treatment of chronic thyroid eye disease.
Shoaib Ugradar, Julia Kang, Andrea L Kossler, Erin Zimmerman, Jenna Braun, Kimberly Cockerham

Eye (Lond)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intense Pulsed Light: A Therapeutic Option for Patients With Rosacea-Related Dry Eye and Blepharospasm.
Anna N Monterastelli, Lucy A Bailey, Kimberly Cockerham

J Neuroophthalmol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.
Kimberly P Cockerham, Lissa Padnick-Silver, Noel Stuertz, Megan Francis-Sedlak, Robert J Holt

Ophthalmol Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid dermopathy responds to teprotumumab therapy.
Ricaurte Crespo-Trevino, Jade Schiffman, Shoaib Ugradar, Kimberly Cockerham, Raymond Douglas

Endocrinol Diabetes Metab Case Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Paradigm Shift in the Management of Thyroid Eye Disease How Teprotumumab Has Changed the Therapeutic Interface.
Shoaib Ugradar, Andrea L Kossler, Raymond Douglas, Kimberly Cockerham

J Neuroophthalmol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.
Kimberly P Cockerham, Lissa Padnick-Silver, Noel Stuertz, Megan Francis-Sedlak, Robert J Holt

Ophthalmol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the Gap between Ophthalmology and Emergency Medicine in Community-Based Emergency Departments (EDs): A Neuro-Ophthalmology Guide for ED Practitioners.
Kristina Thomas, Cindy Ocran, Anna Monterastelli, Alfredo A Sadun, Kimberly P Cockerham

Clin Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusion Center Guidelines for Teprotumumab Infusions: Informed Consent, Safety, and Management of Side Effects.
Julia Kang, Maria Lechuga, Jenna Braun, Andrea Kossler, Raymond Douglas, Kimberly Cockerham

J Infus Nurs· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.
Connie M Sears, Yao Wang, Lucy A Bailey, Roger Turbin, Prem S Subramanian, Kimberly Cockerham

Am J Ophthalmol Case Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative Prophylactic Antibiotics in 1,250 Orbital Surgeries.
Aaron Fay, Nambi Nallasamy, Richard C Allen, Francesco P Bernardini, Jurij R Bilyk, Kimberly Cockerham

Ophthalmic Plast Reconstr Surg· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Malignant Orbital Tumors.
Jacquelyn Laplant, Kimberly Cockerham

J Neurol Surg B Skull Base· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putting the Pieces Back Together: Optimizing Function and Appearance after Orbital Surgery.
Kimberly Cockerham, Jacquelyn Laplant

J Neurol Surg B Skull Base· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis